Document Detail


Increased prevalence of cardiovascular risk factors in patients with acute coronary syndrome and indications for treatment with oral anticoagulation.
MedLine Citation:
PMID:  21928197     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Background: Antiplatelet drugs currently constitute the basic treatment of coronary artery disease (acute coronary syndrome [ACS], stable angina and patients treated with percutaneous coronary interventions [PCI]). The number of patients with indication for dual antiplatelet therapy with comorbidities with high thrombo-embolic risk (such as atrial fibrillation [AF], venous thrombotic disease, valvular diseases) is increasing. That is why the need for simultaneous administration of dual antiplatelet and oral anticoagulant therapy (triple therapy) has become more common recently. The AF is the most common indication for chronic anticoagulation. Because of the lack of large randomised trials regarding triple therapy, characteristics of this group has not been well established. Aim: To assess the presence of cardiovascular (CV) risk factors and concomitant diseases in patients with ACS requiring triple therapy. Methods: Retrospective analysis included 2279 patients diagnosed with ACS who were admitted to the Departments of Cardiology in Cracow in 2008. In this group, 365 (16%) patients had indications for chronic anticoagulation. Demographic and clinical characteristics of these patients were compared with those of patients included in other published registries. Results: Patients requiring triple therapy were aged 73.2 ± 9.5 years. Hypertension was diagnosed in 80%, hyperlipidaemia in 63%, smoking in 36%, prior myocardial infarction in 33%, prior stroke in 15%, previous treatment with PCI in 13%, coronary artery bypass grafting in 7%, diabetes in 36%, heart failure in 46%, anaemia in 33% and chronic ulcer disease or gastroesophageal reflux disease in 9%. The mean left ventricular ejection fraction was 46 ± 15%. Compared with other registries of patients without indications for triple therapy, our patients had significantly more frequently hypertension, diabetes and were older. Conclusions: Patients after an ACS requiring triple therapy have more often a history of comorbidities and CV risk factors when compared with the group of patients with ACS without indication for triple therapy. Kardiol Pol 2011; 69, 9: 907-912.
Authors:
Michał Owsiak; Agnieszka Pelc-Nowicka; Leszek Badacz; Jacek Dubiel; Dariusz Dudek; Grzegorz Gajos; Janusz Grodecki; Piotr Jankowski; Kalina Kawecka-Jaszcz; Ewa Mirek-Bryniarska; Jadwiga Nessler; Piotr Podolec; Jerzy Sadowski; Wiesława Tracz; Michał Zabojszcz; Krzysztof Zmudka; Leszek Bryniarski
Related Documents :
21665917 - Clinical features of neuromyelitis optica in a large japanese cohort: comparison betwee...
22457857 - Serotonin transporter gene (slc6a4) polymorphism in patients with irritable bowel syndr...
19183747 - Update on the clinical utility of fenofibrate in mixed dyslipidemias: mechanisms of act...
21978317 - Epidemiological characteristics of cognitive impairment of multiple sclerosis patients ...
17258387 - Ureteral catheterization in uncomplicated ureterolithotripsy: a randomized, controlled ...
1996587 - Prognostic significance of valvular regurgitation in patients with infective endocarditis.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Kardiologia polska     Volume:  69     ISSN:  0022-9032     ISO Abbreviation:  Kardiol Pol     Publication Date:  2011  
Date Detail:
Created Date:  2011-09-19     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0376352     Medline TA:  Kardiol Pol     Country:  Poland    
Other Details:
Languages:  eng     Pagination:  907-12     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Efficacy and safety of closing postcatheterisation pseudoaneurysms with ultrasound-guided thrombin i...
Next Document:  Echocardiographic quantitative analysis of resting myocardial function for the assessment of viabili...